Dr Reddy’s Laboratories, a Rs.11,600 crore plus second largest pharma company in India, has launched fenofibrate capsules, USP 43 mg and 130 mg a therapeutic equivalent generic version of Antara (fenofibrate) capsules, in the US market on April 22, 2014, following the approval by the US FDA.
The Antara (fenofibrate) capsules brand and generic had US sales of approximately $74 million MAT for the most recent twelve months ending in February 2014 according to IMS Health.
Dr Reddy’s fenofibrate capsules, USP 43 mg is available in bottle counts of 30 and 130 mg are available in bottle counts of 30 and 90.